2022 Could be a Success or a Lost Opportunity for Novavax

InvestorPlace2022-02-05

Novavax, Inc. (NASDAQ:NVAX) has had a tough year with losses of approximately 68%. It has already declined about 37% year-to-date, as well. However, as of Feb. 3, 2022, the stock has a 5-day return of...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Annalz
    2022-02-07
    Annalz
    Excellent point covered both possibilities 😂
  • AhBart
    2022-02-06
    AhBart
    A winding road ahead for Novavax in search for that pot of gold !!! Keep moving and you’ll get there 🤟🏿
  • K74
    2022-02-06
    K74
    Took
  • StayHome
    2022-02-06
    StayHome
    Novavax is late as covid19 vaccine but is still better than never .... so long it's beneficial to mankind 
  • WannaBluffy
    2022-02-06
    WannaBluffy
    Like
  • Lulup
    2022-02-06
    Lulup
    good
Leave a comment
125